Stay updated on Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.

Latest updates to the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference4%

- Check26 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check40 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, indicating a revision. The 'Back to Top' link was removed.SummaryDifference0.3%

- Check47 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%

- Check54 days agoChange DetectedThe web page has updated its facility name and location details, specifically retaining the location of Petah Tikva, Israel, while removing previous location terms and certain drug information. Additionally, the revision number has been updated to v3.0.0.SummaryDifference4%

- Check69 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.